Perrigo | PRGO - Current Assets


Perrigo reported $2.71B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
AbbVie USD 33.53B 4.47B Mar/2026
Abbott USD 25.51B 488M Mar/2026
Bayer EUR 35.3B 2.39B Mar/2026
Bristol-Myers Squibb USD 27.21B 2.18B Mar/2026
Coherus Biosciences USD 206.71M 254.25M Dec/2025
Corcept Therapeutics USD 426.03M 59.43M Mar/2026
Dr.Reddys Laboratories INR 301.79B 4.24B Mar/2026
Eli Lilly USD 54.84B 794M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Merck USD 35.02B 8.5B Mar/2026
Nestle CHF 31.97B 1.46B Dec/2025
Pacira USD 514.96M 33.01M Mar/2026
Perrigo USD 2.71B 85M Mar/2026
Pfizer USD 42.82B 76M Mar/2026
Phibro Animal Health USD 894.07M 31.88M Mar/2026
Prestige Brands USD 431.48M 1.94M Mar/2026
Reckitt Benckiser GBP 4.6B 287M Dec/2024
Sanofi EUR 30.16B 789M Mar/2026
Supernus Pharmaceuticals USD 731.58M 87.4M Mar/2026
Teva Pharmaceutical Industries USD 13.71B 236M Mar/2026
Xeris Pharmaceuticals USD 251.68M 11.37M Mar/2026
Zoetis USD 6.47B 294M Mar/2026